Ross, J., Lee, J. J., Cascarino, S., Baine, M. K., Rekhtman, N., Bready, B., Arfe, A., Daly, R. M., Schoenfeld, A. J., Chan, J. M., Riely, G. J., Kris, M. G., Awad, M. M., Rudin, C. M., Cooper, A. J. (2026). Impact of DLL3 expression and tumor subtype on response to tarlatamab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8087